Delisting risk
CDT · NASDAQ · Biotechnology

CDT Equity (CDT)

Develops and out-licenses repurposed clinical assets through solid-form chemistry, computational analysis, and patent creation.

$0.9420
Pre-market+0.02 (+2.63%)
At close$0.9179(−37.98%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Jun '26Jun '26Jun '26Jun '26Jul '26Jul '26Jul '26Aug '26
Reported$13.10$13.10$13.10$13.10$13.10−$0.56$1.76−$8.71
Estimate
Surprise

RevenueReportedEstimate

Jun '26Jun '26Jun '26Jun '26Jul '26Jul '26Jul '26Aug '26
Reported$696.4M$696.4M$696.4M$696.4M$696.4M$696.4M$750.2M$750.2M
Estimate
Surprise

History

DateEstimateReportedSurprise
Aug 2026−$8.71
Jul 2026$1.76
Jul 2026−$0.56
Jul 2026$13.10

The latest year is open to everyone — the 22 quarters behind it read with an account.

Sign in
Jun 2026
Jun 2026
Jun 2026
Jun 2026
May 2026
Apr 2026
Nov 2025
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Apr 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Aug 12, 2026−$8.71$750.2M−0.7%
Jul 30, 2026$1.76$750.2M+9.3%
Jul 15, 2026−$0.56$696.4M+1.1%
Jul 2, 2026$13.10$696.4M−8.1%

The latest year is open to everyone — the 22 quarters behind it read with an account.

Sign in
Jun 25, 2026
Jun 18, 2026
Jun 11, 2026
Jun 4, 2026
May 28, 2026
Apr 3, 2026
Nov 13, 2025
Aug 14, 2025
May 15, 2025
Mar 28, 2025
Nov 14, 2024
Aug 12, 2024
May 14, 2024
Apr 1, 2024
Nov 20, 2023
Aug 15, 2023
May 16, 2023
Mar 29, 2023
Nov 8, 2022
Aug 12, 2022
May 18, 2022
Mar 30, 2022